BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM $310M
1-Year Return
6.98%
This Quarter Return
-13.36%
1 Year Return
+6.98%
3 Year Return
+59.66%
5 Year Return
–
10 Year Return
–
AUM
$360M
AUM Growth
-$141M
(-28%)
Cap. Flow
-$67.6M
Cap. Flow
% of AUM
-18.8%
Top 10 Holdings %
Top 10 Hldgs %
67.99%
Holding
55
New
10
Increased
7
Reduced
8
Closed
14
Top Buys
1 |
Context Therapeutics
CNTX
|
+$10.3M |
2 |
Viking Therapeutics
VKTX
|
+$5.04M |
3 |
Starwood Property Trust
STWD
|
+$4.29M |
4 |
Pyxis Oncology
PYXS
|
+$3.46M |
5 |
Tourmaline Bio
TRML
|
+$3.45M |
Top Sells
1 |
Robinhood
HOOD
|
+$54M |
2 |
Cullinan Oncology
CGEM
|
+$15.3M |
3 |
enGene Holdings Inc. Warrants
ENGNW
|
+$5.47M |
4 |
MoonLake Immunotherapeutics
MLTX
|
+$5.02M |
5 |
Dell
DELL
|
+$4.71M |
Sector Composition
1 | Healthcare | 71.57% |
2 | Technology | 17.92% |
3 | Financials | 8.96% |
4 | Real Estate | 1.19% |
5 | Industrials | 0.09% |